Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NOVOCART Inject
- Development stage
- Unknown
- Lead developer
- Octane Biotherapeutics
- Modality
- Hydrogel Systems → Drug Delivery Systems, Cell Therapies
- Administration
- Intraarticular
01
Overview
**NOVOCART Inject** is a patient-specific, gel-based matrix-associated autologous chondrocyte implantation product developed by TETEC for repair of localized full-thickness articular-cartilage defects. It combines a patient's expanded autologous chondrocytes with an injectable, in-situ polymerizable PEG-albumin-hyaluronic-acid hydrogel that is delivered into the cartilage defect, including through arthroscopic procedures. The product is intended to retain viable chondrocytes at the defect site and support biological cartilage regeneration rather than pharmacologically modulating a defined molecular target. Public clinical studies have evaluated NOVOCART Inject for knee and hip cartilage defects. ([tetec-ag.de](https://www.tetec-ag.de/de/post/octane-medical-ubernimmt-das-globale-orthobiologiegeschaft-von-b-braun))
- Brand names
- NOVOCART Inject
- Other names
- Autologous chondrocyte implantationACIMatrix-associated autologous chondrocyte implantationM-ACIAutologous chondrocyte suspension
Beyond the preview
Go deeper on NOVOCART Inject.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NOVOCART Inject.